What Is NAD IV Therapy?

NAD IV therapy delivers nicotinamide adenine dinucleotide, a coenzyme present in every living cell, directly into the bloodstream via intravenous (IV) infusion. Substance use depletes the body's natural stores of NAD+, and that depletion links to declining energy levels, persistent brain fog, and a reduced capacity to manage cravings during withdrawal. IV administration lets the molecule reach the brain at full concentration, bypassing the digestive breakdown that oral supplements face. If you're in recovery and wondering why the exhaustion and mental fog persist weeks after stopping, this is part of the answer.

Key Takeaways

• NAD IV therapy replenishes a coenzyme critical to cellular energy production and brain function, both of which substance use actively depletes
• IV delivery gets NAD+ into the bloodstream intact, producing faster and more measurable effects than oral supplementation
• Research points to measurable reductions across specific craving and mood metrics; the numbers from a 50-person study are more striking than most accounts suggest
• Brain fog and low energy levels in early recovery have a cellular explanation that goes beyond feeling unwell
• The therapy has a defined side-effect profile and hard limits on who should use it
• People with liver or kidney conditions, and those who are pregnant, require medical clearance before starting

What Exactly Is NAD+?

Nicotinamide adenine dinucleotide. The name is a mouthful, but the molecule itself is straightforward. NAD+ is a coenzyme found in every cell of the human body, and its primary job is enabling cells to convert food into usable energy. Without adequate NAD+, mitochondria cannot produce ATP efficiently. ATP is the energy currency cells run on, and when its production falters, virtually every biological system feels the strain.

The body also relies on NAD+ for DNA repair and regulation of inflammatory responses. When NAD+ levels drop, cells lose the resources to perform basic maintenance, and the downstream effects surface across multiple systems. Cognitive sharpness falls. Physical stamina drops. The brain's ability to regulate mood and reward becomes unstable.

NAD+ levels decline naturally with age, but addiction accelerates that process sharply. Chronic drug and alcohol use depletes the body's NAD+ stores to a fraction of normal levels. That's why you can enter detox feeling completely wrecked, not just from withdrawal, but because your cells have been running on empty for months or years before you walked through a treatment door.

How Does NAD IV Therapy Work?

The delivery method is what sets NAD IV therapy apart from supplements. Oral NAD+ precursors, such as NMN or NR, have to survive digestion before entering circulation. A meaningful percentage breaks down before it ever reaches target tissues. Intravenous infusion sidesteps that entirely. The coenzyme enters the bloodstream directly and reaches the brain intact.

A single session runs between 90 minutes and four hours, depending on dosage and your condition. Most addiction treatment protocols involve daily infusions over six to ten days, though duration varies by clinic and by the substance you're withdrawing from.

Once in the bloodstream, NAD+ enters cells and drives the metabolic reactions that produce ATP. In the brain, that cellular energy boost supports the synthesis of neurotransmitters including dopamine and serotonin, both of which addiction disrupts over time. NAD+ also activates SIRT1, an enzyme involved in regulating the reward pathways that substances hijack during active use.

A PMC (PubMed Central) review¹ of IV NAD+ in addiction medicine notes that infusions demonstrated complete withdrawal from addictive substances without subjects experiencing the acute agony of withdrawal symptoms in observed cases.

What Are the Benefits of NAD IV Therapy in Recovery?

Reduced cravings and withdrawal symptoms. A 2022 study published in PMC² examined 50 individuals with substance use disorders who had not responded to standard treatment. After NAD infusions, craving scores dropped with a statistical significance of P=1.063E-9. (This number also represents an extremely low probability that the observed results occurred by chance). Anxiety scores fell with P=5.487E-7, and depression scores showed marked improvement. The same data showed a dose-dependent linear relationship between the number of infusions and declining cravings, suggesting the benefit accumulates across sessions.

Improved energy levels. Addiction leaves the body in a state of metabolic debt. Cells running without adequate NAD+ cannot produce ATP efficiently, and that deficit is a core reason why early recovery feels so physically devastating. NAD IV therapy restores the substrate those cells need to generate energy properly. Most patients report noticeable improvements in energy levels within the first few days of treatment, without the crash that follows caffeine or stimulants.

Reduced brain fog. Persistent cognitive cloudiness is a hallmark complaint of early sobriety. Slow processing, difficulty concentrating, poor decision-making. These aren't purely psychological; they reflect genuine neurological impairment from sustained substance use. NAD+ supports neuronal repair and the synthesis of neurotransmitters that govern cognition. As levels restore, mental clarity tends to follow within the first week of infusions.

Cellular repair and reduced oxidative stress. Substance abuse accelerates cellular damage through oxidative stress. NAD+ activates sirtuins, which defend cells against that damage and support DNA repair mechanisms. Sirtuin activation also appears to regulate stress responses and inflammatory signalling, two systems that remain dysregulated well into recovery.

Mood stabilisation. Early sobriety brings emotional flatness, irritability, and unpredictable anxiety. Much of that instability traces to disrupted neurotransmitter production, a gap that NAD+ helps close by restoring the metabolic conditions those reactions depend on. It creates a more stable neurochemical baseline from which psychological treatment can actually land.

How Does NAD IV Therapy Help With Alcohol Addiction?

Alcohol addiction depletes NAD+ through a specific biochemical route. Alcohol metabolism consumes the coenzyme at a high rate, and chronic heavy drinking creates a sustained deficit that persists well into sobriety. The brain rewiring that alcohol addiction produces disrupts the dopamine reward system in ways that leave people feeling unable to experience pleasure or motivation without a drink. Replenishing NAD+ directly addresses that dopamine pathway deficit, helping rebuild the reward system's capacity to respond to natural stimuli.

Early retrospective data from the BR+NAD protocol, developed in 2001 by a clinic in Springfield, Louisiana specifically for opioid and alcohol addiction withdrawal, showed patients experiencing reduced withdrawal severity and cravings compared to baseline. A pilot study reviewing that protocol found that NAD therapy helped reduce fatigue, cravings, anxiety, and stress during the acute withdrawal period, making the early stages of recovery more physically manageable and less likely to end in premature discharge from treatment.

The dehydrogenase enzymes responsible for metabolising alcohol are themselves NAD-dependent. That means an alcohol-depleted system becomes less able to clear the very substance causing the problem, and less able to convert acetaldehyde, alcohol's toxic byproduct, into harmless acetate. Replenishing NAD+ through IV infusion restores some of that enzymatic capacity, accelerating clearance of residual toxins during the early detox days.

What Are the Risks and Side Effects?

NAD IV therapy carries a comparatively low risk profile. The PMC review of IV NAD+ administration found no adverse events when infusions were delivered at an appropriate rate.

Common side effects reported during infusion:

• Nausea, particularly when the drip runs too fast
• Flushing or warmth across the face and chest
• Headache or mild dizziness
• Fatigue immediately following the session
• Muscle cramping in some cases

These generally resolve once the infusion rate is slowed.

NAD IV therapy is not approved by Health Canada as a medical treatment for addiction. Research is still accumulating, and most published studies are retrospective or conducted in small cohorts. Anyone with kidney disease, liver conditions, or who is pregnant should not undergo the therapy without explicit medical clearance.

Cost is a practical barrier for many. Sessions are not covered by provincial health plans, and a full treatment course can run into several thousand dollars. Clinics vary considerably in qualifications and protocols. Check that medical staff hold active licences, that protocols specify drip rate monitoring, and that a physician is reachable during infusions before you commit.

NAD IV therapy does not address the psychological, social, or behavioural dimensions of addiction. It cannot replace counselling, medication-assisted treatment, or structured rehabilitation. At its best, it is one layer inside a broader programme, a support that can reduce fatigue and sharpen your cognitive function enough to make the other work more accessible.

Taking the Next Step

Addiction strips the body of the cellular resources it needs to recover. NAD IV therapy can restore some of those resources directly, improving energy levels, clearing cognitive fog, and easing the physiological weight of withdrawal enough to make real treatment engagement possible. At the Canadian Centre for Addictions, our clinical team integrates supportive therapies alongside evidence-based care to give every client the strongest possible foundation for lasting recovery. Call us today at 1-855-499-9446.

FAQ